This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CHNA Loncar China Biopharma ETF (CHNA) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Loncar China Biopharma ETF (NASDAQ:CHNA) 30 days 90 days 365 days Advanced Chart Get CHNA alerts:Sign Up Key Stats Today's Range$13.53▼$13.5350-Day Range$13.53▼$14.7752-Week Range$13.35▼$22.89Volume9 shsAverage Volume538 shsMarket Capitalization$10.56 millionAssets Under Management$3.74 millionDividend Yield0.44%Net Expense Ratio0.79%Aggregate RatingN/A ETF Overview The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar. Read More Loncar China Biopharma ETF ExpensesTypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.79%0.56%0.56%0.54%0.53%Other Expenses0.00%0.47%0.56%0.52%0.56%Total Expense0.79%0.75%0.76%0.73%0.73%Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%Net Expense0.79%0.60%0.63%0.63%0.60% Receive CHNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CHNA ETF News HeadlinesRoundhill China Dragons ETFOctober 5, 2024 | morningstar.comMHow investors can get in on the China stock rally with ETFsOctober 4, 2024 | finance.yahoo.comThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain sight...September 3 at 2:00 AM | Crypto 101 Media (Ad)Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 VaccinesSeptember 30, 2024 | markets.businessinsider.comLiaoning Chengda Biotechnology Co. Ltd. ASeptember 24, 2024 | wsj.comBuy Rating for Legend Biotech: Strong Market Potential and Strategic Operations Amidst Approval of CARVYKTI in ChinaAugust 28, 2024 | markets.businessinsider.comSee More Headlines CHNA ETF - Frequently Asked Questions What other stocks do shareholders of Loncar China Biopharma ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Loncar China Biopharma ETF investors own include Alibaba Group (BABA), Baidu (BIDU), Nokia (NOK), AT&T (T), Tencent (TCEHY), Tesla (TSLA) and Advanced Micro Devices (AMD). Fund Details IssuerExchange Traded Concepts Fund NameLoncar China Biopharma ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:CHNA Inception Date8/14/2018 Fund ManagerDenise M. Krisko, Habib Moudachirou WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkLoncar China BioPharma Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings89 Fund Statistics Assets Under Management$3.74 million Average Daily Volume$1.20 thousand Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorExchange Traded Concepts, LLC CustodianU.S. Bank, N.A. DistributorQuasar Distributors, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerGTS Miscellaneous Outstanding Shares780,814Beta0.95 Creation Unit50,000 Creation Fee$750.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Top 2 CHNA HoldingsUS DOLLARSHolding Weight: 99.94%DEPOSITS WITH BROKER FOR SHORT POSITIONSHolding Weight: 0.06%Full Holdings Details This page (NASDAQ:CHNA) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Loncar China Biopharma ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Loncar China Biopharma ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
